258 related articles for article (PubMed ID: 24600035)
1. Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01.
Motozono C; Kuse N; Sun X; Rizkallah PJ; Fuller A; Oka S; Cole DK; Sewell AK; Takiguchi M
J Immunol; 2014 Apr; 192(7):3428-34. PubMed ID: 24600035
[TBL] [Abstract][Full Text] [Related]
2. T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions.
Cole DK; Miles KM; Madura F; Holland CJ; Schauenburg AJ; Godkin AJ; Bulek AM; Fuller A; Akpovwa HJ; Pymm PG; Liddy N; Sami M; Li Y; Rizkallah PJ; Jakobsen BK; Sewell AK
J Biol Chem; 2014 Jan; 289(2):628-38. PubMed ID: 24196962
[TBL] [Abstract][Full Text] [Related]
3. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
[TBL] [Abstract][Full Text] [Related]
5. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection.
Wynn KK; Fulton Z; Cooper L; Silins SL; Gras S; Archbold JK; Tynan FE; Miles JJ; McCluskey J; Burrows SR; Rossjohn J; Khanna R
Blood; 2008 Apr; 111(8):4283-92. PubMed ID: 18270323
[TBL] [Abstract][Full Text] [Related]
6. The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.
Liu YC; Chen Z; Burrows SR; Purcell AW; McCluskey J; Rossjohn J; Gras S
J Biol Chem; 2012 Apr; 287(15):12267-76. PubMed ID: 22343629
[TBL] [Abstract][Full Text] [Related]
7. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model.
Knapp B; Omasits U; Bohle B; Maillere B; Ebner C; Schreiner W; Jahn-Schmid B
Mol Immunol; 2009 May; 46(8-9):1839-44. PubMed ID: 19232439
[TBL] [Abstract][Full Text] [Related]
8. A molecular basis for how a single TCR interfaces multiple ligands.
Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
[TBL] [Abstract][Full Text] [Related]
10. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
[TBL] [Abstract][Full Text] [Related]
11. Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes.
Smith SN; Sommermeyer D; Piepenbrink KH; Blevins SJ; Bernhard H; Uckert W; Baker BM; Kranz DM
J Mol Biol; 2013 Nov; 425(22):4496-507. PubMed ID: 23954306
[TBL] [Abstract][Full Text] [Related]
12. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
13. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.
Dunn SM; Rizkallah PJ; Baston E; Mahon T; Cameron B; Moysey R; Gao F; Sami M; Boulter J; Li Y; Jakobsen BK
Protein Sci; 2006 Apr; 15(4):710-21. PubMed ID: 16600963
[TBL] [Abstract][Full Text] [Related]
14. Epitope flexibility and dynamic footprint revealed by molecular dynamics of a pMHC-TCR complex.
Reboul CF; Meyer GR; Porebski BT; Borg NA; Buckle AM
PLoS Comput Biol; 2012; 8(3):e1002404. PubMed ID: 22412359
[TBL] [Abstract][Full Text] [Related]
15. Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein.
Wiertz E; van Gaans-van den Brink J; Hoogerhout P; Poolman J
Eur J Immunol; 1993 Jan; 23(1):232-9. PubMed ID: 7678224
[TBL] [Abstract][Full Text] [Related]
16. Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.
Lanzarotti E; Marcatili P; Nielsen M
Mol Immunol; 2018 Feb; 94():91-97. PubMed ID: 29288899
[TBL] [Abstract][Full Text] [Related]
17. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
[TBL] [Abstract][Full Text] [Related]
18. Salt bridge-forming residues positioned over viral peptides presented by MHC class I impacts T-cell recognition in a binding-dependent manner.
Ji W; Niu L; Peng W; Zhang Y; Cheng H; Gao F; Shi Y; Qi J; Gao GF; Liu WJ
Mol Immunol; 2019 Aug; 112():274-282. PubMed ID: 31226552
[TBL] [Abstract][Full Text] [Related]
19. TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility.
Hawse WF; De S; Greenwood AI; Nicholson LK; Zajicek J; Kovrigin EL; Kranz DM; Garcia KC; Baker BM
J Immunol; 2014 Mar; 192(6):2885-91. PubMed ID: 24523505
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3.
Deng L; Langley RJ; Wang Q; Topalian SL; Mariuzza RA
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14960-5. PubMed ID: 22930819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
